CLOV vs UPB
Clover Health Investments Corp (CLOV) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported UPB revenue for 2024-12-31 was $2.4M. Net income was -$62.8M. Revenue was down 0.4% from 2023-12-31 to 2024-12-31. UPB currently screens at market cap $407.3M.
CLOV currently screens at market cap $1.55B. UPB currently screens at market cap $407.3M.
Not investment advice. Open the CLOV and UPB stock pages for the full models.
Not investment advice.